Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients

Completed · Phase 3 · Has a placebo group

Conditions studied: Hyponatremia

In brief

Demonstrate an improvement in the composite scores of validated neurocognitive tests in elderly subjects with chronic sub-clinical (i.e., asymptomatic) hyponatremia.

Key facts

Study ID
NCT00550459
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
57
Starts
2007-08-01
Expected to finish
2009-03-01
Last updated by the study team
2011-04-28

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.